When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 14 Mar 2025
Last updated: 28 Sep 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • chest pain
  • pericardial rub

Risk factors

  • male sex
  • age 20 to 50 years
  • transmural myocardial infarction
  • cardiac surgery
  • neoplasm
  • viral and bacterial infections
  • uraemia or on dialysis
  • systemic autoimmune disorders
  • pericardial injury
  • mediastinal radiation

Diagnostic investigations

1st investigations to order

  • ECG
  • serum troponin
  • pericardiocentesis
  • C-reactive protein
  • serum urea and electrolytes
  • full blood count
  • liver function tests
  • chest x-ray
  • echocardiography

Investigations to consider

  • blood cultures
  • erythrocyte sedimentation rate
  • creatine kinase
  • autoimmune screen
  • viral screen
  • chest CT or cardiac MRI
  • pericardial biopsy

Treatment algorithm

Contributors

Expert advisers

Shrilla Banerjee, MD, FRCP

Consultant Interventional Cardiologist

East Surrey Hospital

Surrey and Sussex Healthcare NHS Trust

UK

Disclosures

SB has received speaker fees for educational lectures (presentation content was her own) and meeting participation from Menarini, Edwards Lifesciences, Abbott Vascular, and Shockwave IVL. She has also participated in an Advisory Board for Sahajanand Medical Technologies Limited. SB has received travel sponsorship from Biosensors International to attend the PCR meeting in Paris in 2022. She has prepared a manuscript on coronary microvascular dysfunction for Abbott for Cardiovascular News (no royalties).

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:

Resham Baruah MBBS, BSc MRCP, PhD

Consultant Cardiologist

Chelsea and Westminster Hospital NHS Foundation Trust

Royal Brompton & Harefield NHS Foundation Trust

London

UK

Katherine Wu MD

Associate Professor of Medicine

Division of Cardiology

Johns Hopkins Medical Institutions

Baltimore

MD

Disclosures

RB has received honoraria/speakers’ fees from Novartis and Boehringer Ingelheim. KW declares that she has no competing interests.

Peer reviewers

Laura Dobson, MBChB, MD

Consultant Cardiologist

Wythenshawe Hospital

Manchester University Foundation Trust

Manchester

UK

Disclosures

LD declares that she has no competing interests.

Use of this content is subject to our disclaimer